ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 121 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $6,000,000 | -14.3% | 4,665 | -7.7% | 0.00% | +100.0% |
| Q4 2016 | $7,000,000 | +77677.8% | 5,054 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $9,000 | +12.5% | 5,054 | +6.3% | 0.00% | -33.3% |
| Q2 2016 | $8,000 | -20.0% | 4,754 | -9.5% | 0.00% | -25.0% |
| Q1 2016 | $10,000 | -23.1% | 5,254 | -27.6% | 0.00% | -20.0% |
| Q4 2015 | $13,000 | -43.5% | 7,254 | -40.8% | 0.01% | -37.5% |
| Q3 2015 | $23,000 | -62.9% | 12,254 | -8.9% | 0.01% | -61.9% |
| Q2 2015 | $62,000 | -3.1% | 13,454 | -8.2% | 0.02% | 0.0% |
| Q1 2015 | $64,000 | +4.9% | 14,654 | -17.0% | 0.02% | +5.0% |
| Q4 2014 | $61,000 | -17.6% | 17,654 | -0.3% | 0.02% | +33.3% |
| Q3 2014 | $74,000 | -14.0% | 17,704 | -10.2% | 0.02% | -66.7% |
| Q2 2014 | $86,000 | – | 19,704 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
| MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
| Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
| Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
| Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
| OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |